Mkts

Tango Therapeutics, Inc.

NASDAQ: TNGX
$24.70-1.03 (-4.00%)
As of Nov 12, 12:59 PM ET

Key statistics

Day range
23.6025.48
52-week range
7.4934.39
Today
Open25.46
Previous close24.70
Volume192.6K
Valuation
Market cap4.40B
P/E ratio—
EPS (TTM)-0.84
Income & risk
Dividend / yield—
Beta1.21
Avg volume3.11M
Discussion

TNGX News

Stories mentioning TNGX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.0053,8113,1815,3924,11611,60719,875
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development33,53432,10130,81532,80736,44233,93633,26338,654
Sales General & Admin
Total Operating Expenses48,76941,86439,73944,14847,92245,02644,48549,427
Operating Income (Loss)(48,769)(41,864)14,072(40,967)(42,530)(40,910)(32,878)(29,552)
Interest Income
Interest Expense
Other Expense1,0791,380705.00910.001,0741,4761,9561,995
Pretax Income(45,513)(38,804)15,874(38,818)(39,842)(37,621)(29,113)(25,486)
Tax Provision1.00(55.00)(10.00)35.0034.0049.0054.0065.00
Net Income (Loss)(45,514)(38,749)15,884(38,853)(39,876)(37,670)(29,167)(25,551)
Earnings Per Share (Basic)(0.32)(0.33)0.14(0.35)(0.36)(0.34)(0.27)(0.24)
Earnings Per Share (Diluted)(0.32)(0.33)0.13(0.35)(0.36)(0.34)(0.27)(0.24)
Weighted Average Shares Outstanding (Basic)143,576116,166110,966110,541110,301109,227108,507108,314
Weighted Average Shares Outstanding (Diluted)143,576116,166117,782110,541110,301109,227108,507108,314

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TNGX

Tango Therapeutics, Inc. (NASDAQ: TNGX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TNGX. It last traded at $24.70 (Nov 12, 2026, 12:59 PM ET), down 4.0% on the day. That gives Tango Therapeutics a market capitalisation of $4.4B.

Over the past 52 weeks TNGX has traded between $7.49 and $34.39.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $45.5M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$0-$45.5M—
Dec 31, 2025$0-$38.7M—
Sep 30, 2025$53.8M$15.9M29.5%
Jun 30, 2025$3.2M-$38.9M-1221.4%

From Tango Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…